Product Images Levocetirizine Dihydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Levocetirizine Dihydrochloride NDC 10135-639 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The chemical structure for Levocetirizine dihydrochloride, the active component of levocetirizine dihydrochloride tablets USP, is an orally active H 1-receptor antagonist. The chemical name is (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride. Levocetirizine dihydrochloride is the R enantiomer of cetirizine hydrochloride, a racemic compound with antihistaminic properties. The molecular formula of levocetirizine dihydrochloride is C 21H 25ClN 2O 3•2HCl. - levocetirizine 01

The chemical structure for Levocetirizine dihydrochloride, the active component of levocetirizine dihydrochloride tablets USP, is an orally active H 1-receptor antagonist. The chemical name is (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride.  Levocetirizine dihydrochloride is the R enantiomer of cetirizine hydrochloride, a racemic compound with antihistaminic properties. The molecular formula of levocetirizine dihydrochloride is C 21H 25ClN 2O 3•2HCl. - levocetirizine 01

PRINCIPAL DISPLAY PANELNDC 10135-0639-30Levocetirizine Dihydrochloride Tablets, USP5 mg30 TabletsRx Only - levocetirizine 02

PRINCIPAL DISPLAY PANELNDC 10135-0639-30Levocetirizine Dihydrochloride Tablets, USP5 mg30 TabletsRx Only - levocetirizine 02

This is a medication with the NDC code 10135-0639-30. Each tablet contains Levocetirizine Dihydrochloride USP 5mg. The recommended storage temperature is between 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). The package insert should be consulted for proper dosage information. Pharmacies should dispense this medication in a tight, light-resistant container with a child-resistant closure. This medication's manufacturer is Marlex Pharmaceuticals, Inc.*

PRINCIPAL DISPLAY PANELNDC 10135-0639-90Levocetirizine Dihydrochloride Tablets, USP5 mg90 TabletsRx Only - levocetirizine 03

PRINCIPAL DISPLAY PANELNDC 10135-0639-90Levocetirizine Dihydrochloride Tablets, USP5 mg90 TabletsRx Only - levocetirizine 03

This is a medication with the National Drug Code 10135-0639-90. It contains Levocetirizine Dihydrochloride, USP at a concentration of 5mg per tablet. The typical dosage of this medication should be consulted on the package insert. The pharmacist should dispense this medication in a container that is airtight and has a child-resistant closure. The medication should be stored at a temperature between 20° and 25°C (68° and 77°F), with allowed excursions between 15-30°C (59-86°F) according to USP Controlled Tablets, USP Room Temperature. This medication is produced by Marlex Pharmaceuticals, Inc. in New Castle, DE and contains 90 tablets per package.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.